MedTrace Logo

Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients

NCT01501331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2014-11-18

No results posted yet for this study

Summary

The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT) on a daily basis and transmission of data via the Remote Monitoring technology. This may result in early detection of imminent decompensation at a presymptomatic stage. The study will assess the respiratory trends correlation with clinically relevant heart failure events.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

CRTD or ICD (Energen)

RRT measurement by cardiac resynchronization therapy devices and implantable cardioverter defibrillators

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Principal Investigators

  • Giovanni B Forleo, MD, PhD · University of Rome Tor Vergata

  • Luca Santini, MD, PhD · University of Rome Tor Vergata

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501331 on ClinicalTrials.gov